Your browser doesn't support javascript.
loading
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.
Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kaukel, E; Freitag, L; Digel, W; Bischoff, H; García-Campelo, R; Iannotti, N; Reiterer, P; Bover, I; Prendiville, J; Eisenfeld, A J; Oldham, F B; Bandstra, B; Singer, J W; Bonomi, P.
Affiliation
  • Paz-Ares L; Hospital Universitario 12 de Octubre, Servicio de Oncología Médica, Madrid 28041, Spain.
Br J Cancer ; 98(10): 1608-13, 2008 May 20.
Article in En | MEDLINE | ID: mdl-18475293
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyglutamic Acid / Paclitaxel / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2008 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyglutamic Acid / Paclitaxel / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2008 Document type: Article Affiliation country: España Country of publication: Reino Unido